0001179110-16-026230.txt : 20160608
0001179110-16-026230.hdr.sgml : 20160608
20160608190038
ACCESSION NUMBER: 0001179110-16-026230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160608
FILED AS OF DATE: 20160608
DATE AS OF CHANGE: 20160608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allergan plc
CENTRAL INDEX KEY: 0001578845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
BUSINESS PHONE: (216) 523-5000
MAIL ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis plc
DATE OF NAME CHANGE: 20130930
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis Ltd
DATE OF NAME CHANGE: 20130607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHAISON PHILIPPE
CENTRAL INDEX KEY: 0001637140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36867
FILM NUMBER: 161704575
MAIL ADDRESS:
STREET 1: C/O ACTAVIS PLC MORRIS CORP CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
edgar.xml
FORM 4 -
X0306
4
2016-06-08
1
0001578845
Allergan plc
AGN
0001637140
SCHAISON PHILIPPE
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK,
COOLOCK, CO.
DUBLIN
L2
00000
IRELAND
0
1
0
0
EVP, President Allergan Med
Ordinary Shares, par value $0.0001
8620
D
Stock Option (Right to Buy)
112.2
2023-10-31
Ordinary Shares
16152
16152
D
Stock Option (Right to buy)
154.87
2024-02-21
Ordinary Shares
16387
16387
D
Stock Option (Right to buy)
289.75
2025-02-20
Ordinary Shares
8149
8149
D
Stock Option (Right to buy)
307.51
2025-03-17
Ordinary Shares
8676
8676
D
Performance Based Restricted Stock Unit
Ordinary Shares
9344
9344
D
Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
Vests in four equal annual installments commencing on the first anniversary of the grant date (October 31, 2013).
Vests in four equal annual installments commencing on the first anniversary of the grant date (February 21, 2014).
Vests in four equal annual installments commencing on the first anniversary of the grant date (February 20, 2015).
Vests in five equal annual installments commencing on the first anniversary of the grant date (March 17, 2015).
Represents performance-based restricted share units ("PSUs") which will vest as to one-third of the total grant on each of December 31, 2017, 2018 and 2019, subject to the achievement by the Issuer of certain performance criteria. Each PSU represents a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person.
/s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person
2016-06-08